Edwards Lifesciences Corporation Common Stock vs YieldMax AI & Tech Portfolio Option Income ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while YieldMax AI & Tech Portfolio Option Income ETF trades at $43 (market cap $136.17M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 363.1× YieldMax AI & Tech Portfolio Option Income ETF's market cap, and YieldMax AI & Tech Portfolio Option Income ETF is more actively traded (88,095 versus 3,508,027). Which is the better fit depends on your goals.
| EW | GPTY | |
|---|---|---|
Market Cap | $49.44B | $136.17M |
Volume | 3,508,027 | 88,095 |
Sector | Health | Income / Options Overlay |
52-Week High | $95.18 | $50.52 |
52-Week Low | $72.65 | $34.73 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 60 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →GPTY is an actively managed ETF that seeks to provide current income and capital appreciation by holding a concentrated portfolio of 15 to 30 leading AI and technology companies. It utilizes a variety of options strategies, including selling call options on its underlying holdings, to generate weekly distributions while maintaining direct equity exposure to the growth of the AI sector.
Read more on GPTY →